Aramark 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Aramark on December 7, 2023, with the earliest event reported on December 11, 2023. The filing addresses Item 5.02 regarding the departure of the Chief Financial Officer and the appointment of a successor, as well as Item 7.01 for Regulation FD disclosure.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change is the leadership transition in the finance function:
- Departure: Thomas Ondrof, Executive Vice President and Chief Financial Officer, will retire on January 12, 2024.
- Appointment: James Tarangelo, currently Senior Vice President, Finance and Treasurer, will become Senior Vice President and Chief Financial Officer effective January 13, 2024.
- Transition Role: Mr. Ondrof will serve as a Strategic Advisor through May 2024.
Management Commentary, Risks, and Unusual Items
Compensation and Employment Terms for James Tarangelo:
- Base Salary: $625,000 annually.
- Target Bonus: 85% of base salary.
- Equity Awards (FY2024): Recommended grant date fair values include $405,000 in non-qualified stock options, $270,000 in time-based restricted stock units, and $675,000 in performance stock units.
- Severance (Termination without Cause): 18 months of base salary and target bonus, plus pro-rata bonus and benefits continuation.
- Change of Control Severance: 2.0x base salary and 2.0x target bonus payable over two years, plus pro-rata bonus and 24 months of outplacement counseling.
- Restrictive Covenants: Includes 24-month post-employment non-competition, non-solicitation, and non-hire covenants (reduced to 18 months if terminated without Cause).
Compensation and Employment Terms for Thomas Ondrof:
- Strategic Advisor Fee: $5,000 per two-week pay period through May 31, 2024.
- Benefits: Continued participation in basic group medical, dental, and vision programs at the active employee rate until age 65 or election of new employer coverage.
Investor Verification Checklist
- Verify the exact effective dates of the CFO transition (January 12 and 13, 2024).
- Review the attached Exhibits 10.1 and 10.2 for the full legal text of Mr. Tarangelo's employment and non-compete agreements.
- Confirm the specific performance metrics for the $675,000 performance stock units granted to Mr. Tarangelo, as these are established by the Compensation Committee.
- Monitor the company's subsequent filings for any changes to the transition timeline or additional executive departures.